Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Blood-based tests for colorectal cancer screening: do they threaten the survival of the FIT test?

Literature DB >> 25680874

Blood-based tests for colorectal cancer screening: do they threaten the survival of the FIT test?

Robert S Bresalier¹, Scott Kopetz, Dean E Brenner.

Abstract

Colorectal cancer is the second leading cause of cancer death in industrialized nations, accounting for 10% of the total cancer burden with an individual lifetime risk of ~6% in the USA (Siegel et al. in CA Cancer J Clin 62:9-29, 2014, American Cancer Society in Colorectal cancer facts and figures 2011-2013. American Cancer Society, Atlanta, 2011, Siegel et al. in CA Cancer J Clin 61:212-236, 2011). Although numerous screening methods have been incorporated into guidelines for colorectal cancer screening, no guideline includes a noninvasive blood-based test as a recommended option.

Entities: Disease

Mesh：

Substances：
Biomarkers

Year: 2015 PMID： 25680874 DOI： 10.1007/s10620-015-3575-2

Source DB: PubMed Journal: Dig Dis Sci ISSN： 0163-2116 Impact factor: 3.199

60 in total

1. Increased plasma levels of the APC-interacting protein MAPRE1, LRG1, and IGFBP2 preceding a diagnosis of colorectal cancer in women.

Authors: Jon J Ladd; Tina Busald; Melissa M Johnson; Qing Zhang; Sharon J Pitteri; Hong Wang; Dean E Brenner; Paul D Lampe; Raju Kucherlapati; Ziding Feng; Ross L Prentice; Samir M Hanash
Journal: Cancer Prev Res (Phila) Date: 2012-01-25

2. Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group.

Authors: Melissa K Tuck; Daniel W Chan; David Chia; Andrew K Godwin; William E Grizzle; Karl E Krueger; William Rom; Martin Sanda; Lynn Sorbara; Sanford Stass; Wendy Wang; Dean E Brenner
Journal: J Proteome Res Date: 2009-01 Impact factor: 4.466

3. Detection of circulating tumor DNA in early- and late-stage human malignancies.

Authors: Chetan Bettegowda; Mark Sausen; Rebecca J Leary; Isaac Kinde; Yuxuan Wang; Nishant Agrawal; Bjarne R Bartlett; Hao Wang; Brandon Luber; Rhoda M Alani; Emmanuel S Antonarakis; Nilofer S Azad; Alberto Bardelli; Henry Brem; John L Cameron; Clarence C Lee; Leslie A Fecher; Gary L Gallia; Peter Gibbs; Dung Le; Robert L Giuntoli; Michael Goggins; Michael D Hogarty; Matthias Holdhoff; Seung-Mo Hong; Yuchen Jiao; Hartmut H Juhl; Jenny J Kim; Giulia Siravegna; Daniel A Laheru; Calogero Lauricella; Michael Lim; Evan J Lipson; Suely Kazue Nagahashi Marie; George J Netto; Kelly S Oliner; Alessandro Olivi; Louise Olsson; Gregory J Riggins; Andrea Sartore-Bianchi; Kerstin Schmidt; le-Ming Shih; Sueli Mieko Oba-Shinjo; Salvatore Siena; Dan Theodorescu; Jeanne Tie; Timothy T Harkins; Silvio Veronese; Tian-Li Wang; Jon D Weingart; Christopher L Wolfgang; Laura D Wood; Dongmei Xing; Ralph H Hruban; Jian Wu; Peter J Allen; C Max Schmidt; Michael A Choti; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos; Luis A Diaz
Journal: Sci Transl Med Date: 2014-02-19 Impact factor: 17.956

4. Evaluation of tumour-associated antigen (TAA) miniarray in immunodiagnosis of colon cancer.

Authors: W Liu; P Wang; Z Li; W Xu; L Dai; K Wang; J Zhang
Journal: Scand J Immunol Date: 2009-01 Impact factor: 3.487

5. Loss of imprinting of insulin growth factor II gene: a potential heritable biomarker for colon neoplasia predisposition.

Authors: Marcia Cruz-Correa; Hengmi Cui; Francis M Giardiello; Neil R Powe; Linda Hylind; Angela Robinson; David F Hutcheon; David R Kafonek; Sheri Brandenburg; Yiqian Wu; Xiaobing He; Andrew P Feinberg
Journal: Gastroenterology Date: 2004-04 Impact factor: 22.682

6. A circulating ligand for galectin-3 is a haptoglobin-related glycoprotein elevated in individuals with colon cancer.

Authors: Robert S Bresalier; James C Byrd; David Tessler; Joseph Lebel; John Koomen; David Hawke; Elizabeth Half; Kai-Feng Liu; Nachman Mazurek
Journal: Gastroenterology Date: 2004-09 Impact factor: 22.682

7. A radial flow microfluidic device for ultra-high-throughput affinity-based isolation of circulating tumor cells.

Authors: Vasudha Murlidhar; Mina Zeinali; Svetlana Grabauskiene; Mostafa Ghannad-Rezaie; Max S Wicha; Diane M Simeone; Nithya Ramnath; Rishindra M Reddy; Sunitha Nagrath
Journal: Small Date: 2014-07-29 Impact factor: 13.281

Review 8. Blood markers for early detection of colorectal cancer: a systematic review.

Authors: Sabrina Hundt; Ulrike Haug; Hermann Brenner
Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-10 Impact factor: 4.254

9. Multitarget stool DNA testing for colorectal-cancer screening.

Authors: Thomas F Imperiale; David F Ransohoff; Steven H Itzkowitz; Theodore R Levin; Philip Lavin; Graham P Lidgard; David A Ahlquist; Barry M Berger
Journal: N Engl J Med Date: 2014-03-19 Impact factor: 91.245

10. Elevated serum endothelin-1 levels in patients with colorectal cancer; relevance for prognosis.

Authors: C F Peeters; C M Thomas; F C Sweep; P N Span; T Wobbes; T M Ruers
Journal: Int J Biol Markers Date: 2000 Oct-Dec Impact factor: 3.248

15 in total

Review 1. Future microfluidic and nanofluidic modular platforms for nucleic acid liquid biopsy in precision medicine.

Authors: Ana Egatz-Gomez; Ceming Wang; Flora Klacsmann; Zehao Pan; Steve Marczak; Yunshan Wang; Gongchen Sun; Satyajyoti Senapati; Hsueh-Chia Chang
Journal: Biomicrofluidics Date: 2016-05-05 Impact factor: 2.800

Review 2. Incidental diffuse low-grade gliomas: from early detection to preventive neuro-oncological surgery.

Authors: Guilherme Lucas de Oliveira Lima; Marc Zanello; Emmanuel Mandonnet; Luc Taillandier; Johan Pallud; Hugues Duffau
Journal: Neurosurg Rev Date: 2015-11-27 Impact factor: 3.042

3. Is distance to chemotherapy an obstacle to adjuvant care among the N.C. Medicaid-enrolled colon cancer patients?

Authors: Alica S Sparling; Eunyoung Song; Heidi D Klepin; Kristie L Foley
Journal: J Gastrointest Oncol Date: 2016-06

4. STAT3-regulated LncRNA LINC00160 mediates cell proliferation and cell metabolism of prostate cancer cells by repressing RCAN1 expression.

Authors: Wenjing Zhu; Dongya Sheng; Yiqun Shao; Qiang Zhang; Yu Peng
Journal: Mol Cell Biochem Date: 2022-01-24 Impact factor: 3.396

5. Increased MACC1 levels in tissues and blood identify colon adenoma patients at high risk.

Authors: Hassan Ashktorab; Pia Hermann; Mehdi Nouraie; Babak Shokrani; Edward Lee; Tahmineh Haidary; Hassan Brim; Ulrike Stein
Journal: J Transl Med Date: 2016-07-20 Impact factor: 5.531

6. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.

Authors: Saiyad Bastaminejad; Morovat Taherikalani; Reza Ghanbari; Akbar Akbari; Nooshin Shabab; Massoud Saidijam
Journal: Iran Biomed J Date: 2016-07-19

7. New trend in colorectal cancer in Germany: are young patients at increased risk for advanced colorectal cancer?

Authors: Peter C Ambe; Stefan Jansen; Hubert Zirngibl
Journal: World J Surg Oncol Date: 2017-08-23 Impact factor: 2.754

8. CDDO-Me reveals USP7 as a novel target in ovarian cancer cells.

Authors: Dongjun Qin; Weiwei Wang; Hu Lei; Hao Luo; Haiyan Cai; Caixia Tang; Yunzhao Wu; Yingying Wang; Jin Jin; Weilie Xiao; Tongdan Wang; Chunmin Ma; Hanzhang Xu; Jinfu Zhang; Fenghou Gao; Ying-Li Wu
Journal: Oncotarget Date: 2016-11-22

Review 9. Polyphenols Modulating Effects of PD-L1/PD-1 Checkpoint and EMT-Mediated PD-L1 Overexpression in Breast Cancer.

Authors: Samia S Messeha; Najla O Zarmouh; Karam F A Soliman
Journal: Nutrients Date: 2021-05-19 Impact factor: 5.717

10. Evaluation of serum nucleoside diphosphate kinase A for the detection of colorectal cancer.

Authors: Olalla Otero-Estévez; Loretta De Chiara; Leticia Barcia-Castro; María Páez de la Cadena; Francisco Javier Rodríguez-Berrocal; Joaquín Cubiella; Vicent Hernández; Vicenta Soledad Martínez-Zorzano
Journal: Sci Rep Date: 2016-05-25 Impact factor: 4.379